SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 86 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $341,250 | -70.7% | 50,000 | -52.2% | 0.00% | -76.9% |
Q3 2020 | $1,165,000 | +824.6% | 104,524 | +99.1% | 0.01% | +1200.0% |
Q4 2018 | $126,000 | -20.8% | 52,506 | +45.4% | 0.00% | 0.0% |
Q3 2018 | $159,000 | +123.9% | 36,100 | +161.6% | 0.00% | – |
Q1 2018 | $71,000 | – | 13,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
Aristides Capital LLC | 24,302 | $271,000 | 0.19% |